health pharma news today obesity drugs glp-1 Chart: 1 in 8 Americans Now Use for Weight Loss Recent medical advancements in weight
Description
Medicines containing GLP-1 and dual GIP/GLP-1 receptor agonists. Therapeutic Goods Administration
, liraglutide administered to mice with hypertension induced by angiotensin II also normalized blood pressure, which resulted in reduced cardiac hypertrophy and a reduced heart/body weight ratio, both parameters indicative of hypertensive heart disease
doi: 10.2337/dc18-2156
10.1016/j.biopsych.2012.01.035 10 DerrR
Age and sex The BP-lowering effects of GLP-1 RAs appear to be largely consistent across age- and sex-defined subpopulations
The trade-off is a higher total cost due to the mandatory membership fee on top of medication
